PANC OTC
Panacos Pharmaceuticals, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -90.0%
5Y: -82.8%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$180K
-36.6% ▼
5Y CAGR: -46.8%
Gross Profit
$180K
-36.6% ▼
5Y CAGR: -46.8%
Operating Income
$39M
-6.4% ▼
5Y CAGR: +13.8%
Net Income
-$37M
+1.7% ▲
EPS (Diluted)
$-0.70
+6.7% ▲
EBITDA
-$38M
+6.6% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2003 | FY2004 | FY2005 | FY2006 | FY2007 |
|---|---|---|---|---|---|
| Revenue | $1M | $1M | $1M | $284K | $180K |
| YoY Growth | -74.5% | +24.0% | -21.5% | -72.9% | -36.6% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $1M | $1M | $1M | $284K | $180K |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| R&D Expenses | $4M | $11M | $20M | $25M | $25M |
| SG&A Expenses | $950K | $2M | $8M | $17M | $13M |
| Operating Expenses | -$3M | -$11M | -$59M | -$41M | -$39M |
| Operating Income | $4M | $12M | $60M | $42M | $39M |
| Operating Margin | 401.8% | 895.2% | 5718.2% | 14681.3% | 21678.9% |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | $0 | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$5M | -$12M | -$59M | -$38M | -$37M |
| Net Margin | -418.2% | -900.4% | -5631.8% | -13419.0% | -20810.6% |
| EPS (Diluted) | $-1.98 | $-14.51 | $-1.72 | $-0.75 | $-0.70 |
| EBITDA | -$4M | -$12M | -$40M | -$41M | -$38M |
| Shares Outstanding | 2M | 5M | 34M | 51M | 53M |